Aastveit AH - Search Results

1

Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

Jungner I, Sniderman AD, Furberg C, Aastveit AH, Holme I, Walldius G. Jungner I, et al. Among authors: aastveit ah. Am J Cardiol. 2006 Apr 1;97(7):943-6. doi: 10.1016/j.amjcard.2005.10.062. Epub 2006 Feb 13. Am J Cardiol. 2006. PMID: 16563891

2

Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.

Sniderman AD, Holme I, Aastveit A, Furberg C, Walldius G, Jungner I. Sniderman AD, et al. Am J Cardiol. 2007 Jul 15;100(2):217-21. doi: 10.1016/j.amjcard.2007.02.086. Epub 2007 May 30. Am J Cardiol. 2007. PMID: 17631073

3

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. Walldius G, et al. Among authors: aastveit ah. Clin Chem Lab Med. 2004;42(12):1355-63. doi: 10.1515/CCLM.2004.254. Clin Chem Lab Med. 2004. PMID: 15576296

4

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. Walldius G, et al. Among authors: aastveit ah. Lancet. 2001 Dec 15;358(9298):2026-33. doi: 10.1016/S0140-6736(01)07098-2. Lancet. 2001. PMID: 11755609

5

Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study.

Walldius G, Aastveit AH, Jungner I. Walldius G, et al. Among authors: aastveit ah. J Intern Med. 2006 Mar;259(3):259-66. doi: 10.1111/j.1365-2796.2005.01610.x. J Intern Med. 2006. PMID: 16476103 Free article.

6

Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population.

Holzmann MJ, Aastveit A, Hammar N, Jungner I, Walldius G, Holme I. Holzmann MJ, et al. Ann Med. 2012 Sep;44(6):607-15. doi: 10.3109/07853890.2011.582136. Epub 2011 May 25. Ann Med. 2012. PMID: 21612332 Free article.

7

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G. Sniderman AD, et al. J Intern Med. 2006 May;259(5):455-61. doi: 10.1111/j.1365-2796.2006.01649.x. J Intern Med. 2006. PMID: 16629851 Free article.

8

Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Holme I, et al. Among authors: aastveit ah. Ann Med. 2009;41(7):522-32. doi: 10.1080/07853890903089453. Ann Med. 2009. PMID: 19657769 Free article.

9

Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Holme I, et al. Among authors: aastveit ah. Eur J Heart Fail. 2009 Nov;11(11):1036-42. doi: 10.1093/eurjhf/hfp129. Epub 2009 Oct 3. Eur J Heart Fail. 2009. PMID: 19801574 Free article.

10

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Holme I, et al. Among authors: aastveit ah. Atherosclerosis. 2010 Nov;213(1):299-305. doi: 10.1016/j.atherosclerosis.2010.08.049. Epub 2010 Aug 19. Atherosclerosis. 2010. PMID: 20843515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters